nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—migraine—Prednisone—systemic lupus erythematosus	0.119	0.341	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—systemic lupus erythematosus	0.115	0.33	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.115	0.33	CpDpCtD
Acetylsalicylic acid—PTGS2—systemic lupus erythematosus	0.0903	0.529	CbGaD
Acetylsalicylic acid—ALB—systemic lupus erythematosus	0.0805	0.471	CbGaD
Acetylsalicylic acid—PTGS2—Dapsone—systemic lupus erythematosus	0.0211	0.0792	CbGbCtD
Acetylsalicylic acid—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0183	0.0687	CbGbCtD
Acetylsalicylic acid—PTGS1—Dapsone—systemic lupus erythematosus	0.0178	0.0669	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—systemic lupus erythematosus	0.0157	0.0589	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—systemic lupus erythematosus	0.0128	0.0479	CbGbCtD
Acetylsalicylic acid—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0115	0.0433	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dapsone—systemic lupus erythematosus	0.0103	0.0386	CbGbCtD
Acetylsalicylic acid—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0103	0.0385	CbGbCtD
Acetylsalicylic acid—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0101	0.0378	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—systemic lupus erythematosus	0.00921	0.0346	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00912	0.0343	CbGbCtD
Acetylsalicylic acid—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0089	0.0335	CbGbCtD
Acetylsalicylic acid—CYP2C19—Dapsone—systemic lupus erythematosus	0.00862	0.0324	CbGbCtD
Acetylsalicylic acid—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00795	0.0299	CbGbCtD
Acetylsalicylic acid—CYP2C9—Dapsone—systemic lupus erythematosus	0.00716	0.0269	CbGbCtD
Acetylsalicylic acid—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00715	0.0269	CbGbCtD
Acetylsalicylic acid—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00675	0.0254	CbGbCtD
Acetylsalicylic acid—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00603	0.0226	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—systemic lupus erythematosus	0.00597	0.0224	CbGbCtD
Acetylsalicylic acid—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.00566	0.0213	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00543	0.0204	CbGbCtD
Acetylsalicylic acid—ABCB1—Betamethasone—systemic lupus erythematosus	0.00517	0.0194	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—systemic lupus erythematosus	0.0051	0.0192	CbGbCtD
Acetylsalicylic acid—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00484	0.0182	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—systemic lupus erythematosus	0.00482	0.0181	CbGbCtD
Acetylsalicylic acid—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00471	0.0177	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—systemic lupus erythematosus	0.00462	0.0174	CbGbCtD
Acetylsalicylic acid—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00457	0.0172	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00444	0.0167	CbGbCtD
Acetylsalicylic acid—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00373	0.014	CbGbCtD
Acetylsalicylic acid—CYP2C9—cardial valve—systemic lupus erythematosus	0.00335	0.0635	CbGeAlD
Acetylsalicylic acid—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0031	0.0116	CbGbCtD
Acetylsalicylic acid—TP53—manual digit—systemic lupus erythematosus	0.00309	0.0586	CbGeAlD
Acetylsalicylic acid—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00301	0.0113	CbGbCtD
Acetylsalicylic acid—ABCB1—Methotrexate—systemic lupus erythematosus	0.00242	0.00908	CbGbCtD
Acetylsalicylic acid—TP53—endothelium—systemic lupus erythematosus	0.00192	0.0365	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—systemic lupus erythematosus	0.00189	0.0359	CbGeAlD
Acetylsalicylic acid—HSPA5—blood plasma—systemic lupus erythematosus	0.00165	0.0312	CbGeAlD
Acetylsalicylic acid—CYP2C19—urine—systemic lupus erythematosus	0.000933	0.0177	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—systemic lupus erythematosus	0.00091	0.0172	CbGeAlD
Acetylsalicylic acid—NFKBIA—connective tissue—systemic lupus erythematosus	0.000895	0.017	CbGeAlD
Acetylsalicylic acid—HSPA5—connective tissue—systemic lupus erythematosus	0.000877	0.0166	CbGeAlD
Acetylsalicylic acid—NFKBIA—nephron tubule—systemic lupus erythematosus	0.000867	0.0164	CbGeAlD
Acetylsalicylic acid—HSPA5—nephron tubule—systemic lupus erythematosus	0.00085	0.0161	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—systemic lupus erythematosus	0.000822	0.0156	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—systemic lupus erythematosus	0.000809	0.0153	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—systemic lupus erythematosus	0.000792	0.015	CbGeAlD
Acetylsalicylic acid—TP53—kidney—systemic lupus erythematosus	0.000775	0.0147	CbGeAlD
Acetylsalicylic acid—NFKBIA—kidney—systemic lupus erythematosus	0.000762	0.0144	CbGeAlD
Acetylsalicylic acid—TP53—cortex of kidney—systemic lupus erythematosus	0.000755	0.0143	CbGeAlD
Acetylsalicylic acid—RPS6KA3—connective tissue—systemic lupus erythematosus	0.000747	0.0142	CbGeAlD
Acetylsalicylic acid—HSPA5—kidney—systemic lupus erythematosus	0.000747	0.0141	CbGeAlD
Acetylsalicylic acid—NFKBIA—cortex of kidney—systemic lupus erythematosus	0.000742	0.0141	CbGeAlD
Acetylsalicylic acid—HSPA5—cortex of kidney—systemic lupus erythematosus	0.000727	0.0138	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nephron tubule—systemic lupus erythematosus	0.000724	0.0137	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—systemic lupus erythematosus	0.000723	0.0137	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—systemic lupus erythematosus	0.000665	0.0126	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—systemic lupus erythematosus	0.000655	0.0124	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—systemic lupus erythematosus	0.000641	0.0122	CbGeAlD
Acetylsalicylic acid—RPS6KA3—kidney—systemic lupus erythematosus	0.000636	0.012	CbGeAlD
Acetylsalicylic acid—TP53—tendon—systemic lupus erythematosus	0.000626	0.0119	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cortex of kidney—systemic lupus erythematosus	0.000619	0.0117	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—systemic lupus erythematosus	0.000615	0.0117	CbGeAlD
Acetylsalicylic acid—TP53—bone marrow—systemic lupus erythematosus	0.000606	0.0115	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—systemic lupus erythematosus	0.000603	0.0114	CbGeAlD
Acetylsalicylic acid—NFKBIA—bone marrow—systemic lupus erythematosus	0.000596	0.0113	CbGeAlD
Acetylsalicylic acid—HSPA5—bone marrow—systemic lupus erythematosus	0.000584	0.0111	CbGeAlD
Acetylsalicylic acid—IKBKB—connective tissue—systemic lupus erythematosus	0.000551	0.0104	CbGeAlD
Acetylsalicylic acid—TP53—lung—systemic lupus erythematosus	0.000549	0.0104	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—systemic lupus erythematosus	0.000546	0.0103	CbGeAlD
Acetylsalicylic acid—NFKBIA—lung—systemic lupus erythematosus	0.00054	0.0102	CbGeAlD
Acetylsalicylic acid—HSPA5—lung—systemic lupus erythematosus	0.000529	0.01	CbGeAlD
Acetylsalicylic acid—RPS6KA3—tendon—systemic lupus erythematosus	0.000513	0.00973	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—systemic lupus erythematosus	0.000508	0.00963	CbGeAlD
Acetylsalicylic acid—EDNRA—cortex of kidney—systemic lupus erythematosus	0.000503	0.00954	CbGeAlD
Acetylsalicylic acid—SLC22A6—nephron tubule—systemic lupus erythematosus	0.0005	0.00948	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—systemic lupus erythematosus	0.0005	0.00948	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—systemic lupus erythematosus	0.000498	0.00944	CbGeAlD
Acetylsalicylic acid—RPS6KA3—bone marrow—systemic lupus erythematosus	0.000497	0.00942	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—systemic lupus erythematosus	0.00049	0.00928	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—systemic lupus erythematosus	0.000489	0.00928	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood plasma—systemic lupus erythematosus	0.000487	0.00922	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—systemic lupus erythematosus	0.000482	0.00912	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—systemic lupus erythematosus	0.000472	0.00894	CbGeAlD
Acetylsalicylic acid—IKBKB—cortex of kidney—systemic lupus erythematosus	0.000457	0.00866	CbGeAlD
Acetylsalicylic acid—SLC22A7—kidney—systemic lupus erythematosus	0.000455	0.00863	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lung—systemic lupus erythematosus	0.000451	0.00854	CbGeAlD
Acetylsalicylic acid—SLC22A7—cortex of kidney—systemic lupus erythematosus	0.000443	0.0084	CbGeAlD
Acetylsalicylic acid—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000428	0.00811	CbGeAlD
Acetylsalicylic acid—CYP2C8—blood plasma—systemic lupus erythematosus	0.000425	0.00805	CbGeAlD
Acetylsalicylic acid—EDNRA—tendon—systemic lupus erythematosus	0.000417	0.00791	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nervous system—systemic lupus erythematosus	0.000417	0.00791	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—systemic lupus erythematosus	0.000403	0.00764	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—systemic lupus erythematosus	0.000402	0.00761	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—systemic lupus erythematosus	0.000388	0.00735	CbGeAlD
Acetylsalicylic acid—IKBKB—tendon—systemic lupus erythematosus	0.000379	0.00718	CbGeAlD
Acetylsalicylic acid—CYP2C9—blood plasma—systemic lupus erythematosus	0.000377	0.00715	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—systemic lupus erythematosus	0.000371	0.00703	CbGeAlD
Acetylsalicylic acid—EDNRA—lung—systemic lupus erythematosus	0.000366	0.00694	CbGeAlD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—systemic lupus erythematosus	0.000354	0.305	CrCbGaD
Acetylsalicylic acid—PTGS1—blood plasma—systemic lupus erythematosus	0.000345	0.00653	CbGeAlD
Acetylsalicylic acid—IKBKB—lung—systemic lupus erythematosus	0.000333	0.0063	CbGeAlD
Acetylsalicylic acid—PTGS2—blood plasma—systemic lupus erythematosus	0.000329	0.00624	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—systemic lupus erythematosus	0.000308	0.00584	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—systemic lupus erythematosus	0.000297	0.00562	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.000228	0.118	CbGdCrCtD
Acetylsalicylic acid—Salsalate—PTGS2—systemic lupus erythematosus	0.000206	0.178	CrCbGaD
Acetylsalicylic acid—ABCB1—blood plasma—systemic lupus erythematosus	0.000204	0.00386	CbGeAlD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—systemic lupus erythematosus	0.000203	0.175	CrCbGaD
Acetylsalicylic acid—CYP2C8—kidney—systemic lupus erythematosus	0.000193	0.00365	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—systemic lupus erythematosus	0.000192	0.0991	CbGdCrCtD
Acetylsalicylic acid—TP53—Danazol—Hydrocortisone—systemic lupus erythematosus	0.000185	0.0957	CbGdCrCtD
Acetylsalicylic acid—PTGS1—connective tissue—systemic lupus erythematosus	0.000183	0.00348	CbGeAlD
Acetylsalicylic acid—PTGS2—connective tissue—systemic lupus erythematosus	0.000175	0.00332	CbGeAlD
Acetylsalicylic acid—TP53—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000167	0.0863	CbGdCrCtD
Acetylsalicylic acid—PTGS1—skin of body—systemic lupus erythematosus	0.000166	0.00314	CbGeAlD
Acetylsalicylic acid—TP53—Danazol—Prednisone—systemic lupus erythematosus	0.000159	0.0825	CbGdCrCtD
Acetylsalicylic acid—PTGS2—skin of body—systemic lupus erythematosus	0.000158	0.003	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—PTGS2—systemic lupus erythematosus	0.000158	0.136	CrCbGaD
Acetylsalicylic acid—PTGS1—kidney—systemic lupus erythematosus	0.000156	0.00296	CbGeAlD
Acetylsalicylic acid—PTGS2—kidney—systemic lupus erythematosus	0.000149	0.00283	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000138	0.0714	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000136	0.0703	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000136	0.0703	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000133	0.0687	CbGdCrCtD
Acetylsalicylic acid—TP53—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000133	0.0686	CbGdCrCtD
Acetylsalicylic acid—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000128	0.00243	CbGeAlD
Acetylsalicylic acid—Salicylic acid—PTGS2—systemic lupus erythematosus	0.000127	0.109	CrCbGaD
Acetylsalicylic acid—PTGS1—tendon—systemic lupus erythematosus	0.000126	0.00239	CbGeAlD
Acetylsalicylic acid—PTGS2—tendon—systemic lupus erythematosus	0.000121	0.00228	CbGeAlD
Acetylsalicylic acid—PTGS2—bone marrow—systemic lupus erythematosus	0.000117	0.00221	CbGeAlD
Acetylsalicylic acid—Salicylic acid—ALB—systemic lupus erythematosus	0.000113	0.0973	CrCbGaD
Acetylsalicylic acid—PTGS1—lung—systemic lupus erythematosus	0.000111	0.0021	CbGeAlD
Acetylsalicylic acid—PTGS2—lung—systemic lupus erythematosus	0.000106	0.002	CbGeAlD
Acetylsalicylic acid—ABCB1—nephron tubule—systemic lupus erythematosus	0.000105	0.00199	CbGeAlD
Acetylsalicylic acid—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.00191	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000103	0.00188	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000103	0.00188	CcSEcCtD
Acetylsalicylic acid—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.00188	CcSEcCtD
Acetylsalicylic acid—Syncope—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.00188	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.00187	CcSEcCtD
Acetylsalicylic acid—PTGS1—nervous system—systemic lupus erythematosus	0.000102	0.00194	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000102	0.00187	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000102	0.00187	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000102	0.00187	CcSEcCtD
Acetylsalicylic acid—Convulsion—Cyclosporine—systemic lupus erythematosus	0.000102	0.00186	CcSEcCtD
Acetylsalicylic acid—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000101	0.00185	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000101	0.00184	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Cyclosporine—systemic lupus erythematosus	9.99e-05	0.00183	CcSEcCtD
Acetylsalicylic acid—Chest pain—Cyclosporine—systemic lupus erythematosus	9.99e-05	0.00183	CcSEcCtD
Acetylsalicylic acid—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	9.92e-05	0.00181	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	9.89e-05	0.00181	CcSEcCtD
Acetylsalicylic acid—PTGS1—central nervous system—systemic lupus erythematosus	9.87e-05	0.00187	CbGeAlD
Acetylsalicylic acid—Urticaria—Leflunomide—systemic lupus erythematosus	9.86e-05	0.0018	CcSEcCtD
Acetylsalicylic acid—PTGS2—nervous system—systemic lupus erythematosus	9.79e-05	0.00186	CbGeAlD
Acetylsalicylic acid—Angioedema—Prednisolone—systemic lupus erythematosus	9.76e-05	0.00179	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	9.75e-05	0.00178	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	9.75e-05	0.00178	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Azathioprine—systemic lupus erythematosus	9.68e-05	0.00177	CcSEcCtD
Acetylsalicylic acid—Confusional state—Cyclosporine—systemic lupus erythematosus	9.66e-05	0.00177	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—systemic lupus erythematosus	9.6e-05	0.00176	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	9.58e-05	0.00175	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—systemic lupus erythematosus	9.58e-05	0.00175	CcSEcCtD
Acetylsalicylic acid—Angioedema—Hydrocortisone—systemic lupus erythematosus	9.53e-05	0.00174	CcSEcCtD
Acetylsalicylic acid—PTGS2—central nervous system—systemic lupus erythematosus	9.43e-05	0.00179	CbGeAlD
Acetylsalicylic acid—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	9.42e-05	0.00172	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—systemic lupus erythematosus	9.39e-05	0.00172	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	9.38e-05	0.00172	CcSEcCtD
Acetylsalicylic acid—Vertigo—Hydrocortisone—systemic lupus erythematosus	9.37e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Syncope—Hydrocortisone—systemic lupus erythematosus	9.36e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	9.35e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—systemic lupus erythematosus	9.31e-05	0.0017	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	9.26e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisolone—systemic lupus erythematosus	9.25e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—ABCB1—kidney—systemic lupus erythematosus	9.23e-05	0.00175	CbGeAlD
Acetylsalicylic acid—Hypertension—Prednisolone—systemic lupus erythematosus	9.22e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—Shock—Mycophenolate mofetil—systemic lupus erythematosus	9.19e-05	0.00168	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	9.17e-05	0.00168	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	9.15e-05	0.00167	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Leflunomide—systemic lupus erythematosus	9.15e-05	0.00167	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	9.12e-05	0.00167	CcSEcCtD
Acetylsalicylic acid—Convulsion—Hydrocortisone—systemic lupus erythematosus	9.04e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	9.03e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—Hypertension—Hydrocortisone—systemic lupus erythematosus	9.01e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Azathioprine—systemic lupus erythematosus	8.99e-05	0.00165	CcSEcCtD
Acetylsalicylic acid—ABCB1—cortex of kidney—systemic lupus erythematosus	8.99e-05	0.0017	CbGeAlD
Acetylsalicylic acid—Angioedema—Triamcinolone—systemic lupus erythematosus	8.98e-05	0.00164	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—systemic lupus erythematosus	8.96e-05	0.00164	CcSEcCtD
Acetylsalicylic acid—Angioedema—Methylprednisolone—systemic lupus erythematosus	8.96e-05	0.00164	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—systemic lupus erythematosus	8.92e-05	0.00163	CcSEcCtD
Acetylsalicylic acid—Vertigo—Triamcinolone—systemic lupus erythematosus	8.83e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Syncope—Triamcinolone—systemic lupus erythematosus	8.81e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methylprednisolone—systemic lupus erythematosus	8.81e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Syncope—Methylprednisolone—systemic lupus erythematosus	8.79e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Pruritus—Leflunomide—systemic lupus erythematosus	8.78e-05	0.00161	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	8.72e-05	0.00159	CcSEcCtD
Acetylsalicylic acid—Dizziness—Azathioprine—systemic lupus erythematosus	8.69e-05	0.00159	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	8.63e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	8.61e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisolone—systemic lupus erythematosus	8.58e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cyclosporine—systemic lupus erythematosus	8.54e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Somnolence—Cyclosporine—systemic lupus erythematosus	8.52e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	8.51e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Convulsion—Triamcinolone—systemic lupus erythematosus	8.51e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—systemic lupus erythematosus	8.51e-05	0.00156	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Leflunomide—systemic lupus erythematosus	8.49e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methylprednisolone—systemic lupus erythematosus	8.49e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Hypertension—Triamcinolone—systemic lupus erythematosus	8.48e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Hypertension—Methylprednisolone—systemic lupus erythematosus	8.46e-05	0.00155	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Cyclosporine—systemic lupus erythematosus	8.43e-05	0.00154	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	8.43e-05	0.00154	CcSEcCtD
Acetylsalicylic acid—Shock—Hydrocortisone—systemic lupus erythematosus	8.38e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Vomiting—Azathioprine—systemic lupus erythematosus	8.36e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methylprednisolone—systemic lupus erythematosus	8.34e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	8.33e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	8.32e-05	0.0431	CbGdCrCtD
Acetylsalicylic acid—Tachycardia—Hydrocortisone—systemic lupus erythematosus	8.31e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	8.31e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—systemic lupus erythematosus	8.3e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Rash—Azathioprine—systemic lupus erythematosus	8.29e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Azathioprine—systemic lupus erythematosus	8.28e-05	0.00151	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—systemic lupus erythematosus	8.28e-05	0.00151	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	8.23e-05	0.00151	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	8.23e-05	0.0015	CcSEcCtD
Acetylsalicylic acid—Dizziness—Leflunomide—systemic lupus erythematosus	8.21e-05	0.0015	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	8.19e-05	0.0424	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	8.19e-05	0.0424	CbGdCrCtD
Acetylsalicylic acid—Angioedema—Betamethasone—systemic lupus erythematosus	8.14e-05	0.00149	CcSEcCtD
Acetylsalicylic acid—Angioedema—Dexamethasone—systemic lupus erythematosus	8.14e-05	0.00149	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methylprednisolone—systemic lupus erythematosus	8.07e-05	0.00148	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	8.02e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Vertigo—Betamethasone—systemic lupus erythematosus	8.01e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Vertigo—Dexamethasone—systemic lupus erythematosus	8.01e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	8.01e-05	0.0414	CbGdCrCtD
Acetylsalicylic acid—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	8e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Syncope—Dexamethasone—systemic lupus erythematosus	7.99e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Syncope—Betamethasone—systemic lupus erythematosus	7.99e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—systemic lupus erythematosus	7.96e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—systemic lupus erythematosus	7.93e-05	0.0015	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	7.89e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Vomiting—Leflunomide—systemic lupus erythematosus	7.89e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Shock—Triamcinolone—systemic lupus erythematosus	7.89e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Shock—Methylprednisolone—systemic lupus erythematosus	7.87e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	7.83e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—systemic lupus erythematosus	7.83e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Rash—Leflunomide—systemic lupus erythematosus	7.83e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—systemic lupus erythematosus	7.82e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Leflunomide—systemic lupus erythematosus	7.82e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Nausea—Azathioprine—systemic lupus erythematosus	7.81e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Methylprednisolone—systemic lupus erythematosus	7.81e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	7.75e-05	0.00142	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	7.73e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Convulsion—Betamethasone—systemic lupus erythematosus	7.72e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—systemic lupus erythematosus	7.72e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	7.7e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Hypertension—Betamethasone—systemic lupus erythematosus	7.7e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—systemic lupus erythematosus	7.7e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Urticaria—Cyclosporine—systemic lupus erythematosus	7.61e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	7.49e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—systemic lupus erythematosus	7.49e-05	0.00137	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—systemic lupus erythematosus	7.45e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.42e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—Nausea—Leflunomide—systemic lupus erythematosus	7.37e-05	0.00135	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	7.27e-05	0.00133	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	7.27e-05	0.00133	CcSEcCtD
Acetylsalicylic acid—ABCB1—bone marrow—systemic lupus erythematosus	7.22e-05	0.00137	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—systemic lupus erythematosus	7.18e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—systemic lupus erythematosus	7.17e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—systemic lupus erythematosus	7.16e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—systemic lupus erythematosus	7.16e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—systemic lupus erythematosus	7.15e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—systemic lupus erythematosus	7.13e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	7.12e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	7.12e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—systemic lupus erythematosus	7.1e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Betamethasone—systemic lupus erythematosus	7.1e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—systemic lupus erythematosus	7.09e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	7.06e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—systemic lupus erythematosus	7.06e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	7.04e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	7.03e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	7.03e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	7.02e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—systemic lupus erythematosus	6.97e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—systemic lupus erythematosus	6.96e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—systemic lupus erythematosus	6.95e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—systemic lupus erythematosus	6.93e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.89e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.82e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Pruritus—Cyclosporine—systemic lupus erythematosus	6.78e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.76e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—systemic lupus erythematosus	6.73e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—systemic lupus erythematosus	6.7e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.61e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—systemic lupus erythematosus	6.61e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.61e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.59e-05	0.00121	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.55e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—ABCB1—lung—systemic lupus erythematosus	6.54e-05	0.00124	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.42e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—systemic lupus erythematosus	6.4e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—systemic lupus erythematosus	6.4e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.39e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—systemic lupus erythematosus	6.37e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.35e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Dizziness—Cyclosporine—systemic lupus erythematosus	6.34e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—systemic lupus erythematosus	6.33e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.27e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—systemic lupus erythematosus	6.23e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—systemic lupus erythematosus	6.18e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	6.18e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—systemic lupus erythematosus	6.12e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cyclosporine—systemic lupus erythematosus	6.09e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—ABCB1—nervous system—systemic lupus erythematosus	6.06e-05	0.00115	CbGeAlD
Acetylsalicylic acid—Rash—Cyclosporine—systemic lupus erythematosus	6.04e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.03e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.02e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—systemic lupus erythematosus	6e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.99e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.99e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.94e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.91e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.89e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.89e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.89e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—ABCB1—central nervous system—systemic lupus erythematosus	5.83e-05	0.00111	CbGeAlD
Acetylsalicylic acid—Vertigo—Methotrexate—systemic lupus erythematosus	5.83e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.83e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—systemic lupus erythematosus	5.81e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—systemic lupus erythematosus	5.78e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—systemic lupus erythematosus	5.78e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—systemic lupus erythematosus	5.76e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Nausea—Cyclosporine—systemic lupus erythematosus	5.69e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Pruritus—Triamcinolone—systemic lupus erythematosus	5.67e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.66e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.63e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—systemic lupus erythematosus	5.62e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—systemic lupus erythematosus	5.58e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.55e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—systemic lupus erythematosus	5.52e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—systemic lupus erythematosus	5.52e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—systemic lupus erythematosus	5.5e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—systemic lupus erythematosus	5.49e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.47e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.41e-05	0.00099	CcSEcCtD
Acetylsalicylic acid—Rash—Hydrocortisone—systemic lupus erythematosus	5.37e-05	0.000982	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.36e-05	0.000981	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000976	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—systemic lupus erythematosus	5.3e-05	0.00097	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	5.29e-05	0.000968	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methylprednisolone—systemic lupus erythematosus	5.29e-05	0.000968	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—systemic lupus erythematosus	5.22e-05	0.000955	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.18e-05	0.000948	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—systemic lupus erythematosus	5.18e-05	0.000947	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—systemic lupus erythematosus	5.15e-05	0.000941	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—systemic lupus erythematosus	5.15e-05	0.000941	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	5.12e-05	0.000936	CcSEcCtD
Acetylsalicylic acid—Vomiting—Triamcinolone—systemic lupus erythematosus	5.1e-05	0.000932	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.09e-05	0.00093	CcSEcCtD
Acetylsalicylic acid—Nausea—Hydrocortisone—systemic lupus erythematosus	5.06e-05	0.000925	CcSEcCtD
Acetylsalicylic acid—Rash—Triamcinolone—systemic lupus erythematosus	5.05e-05	0.000925	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.05e-05	0.000924	CcSEcCtD
Acetylsalicylic acid—Rash—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.000923	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.04e-05	0.000922	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—systemic lupus erythematosus	5.03e-05	0.00092	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.98e-05	0.00091	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.98e-05	0.00091	CcSEcCtD
Acetylsalicylic acid—Dizziness—Betamethasone—systemic lupus erythematosus	4.81e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Dizziness—Dexamethasone—systemic lupus erythematosus	4.81e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—systemic lupus erythematosus	4.76e-05	0.000871	CcSEcCtD
Acetylsalicylic acid—Nausea—Methylprednisolone—systemic lupus erythematosus	4.75e-05	0.000869	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000863	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—systemic lupus erythematosus	4.71e-05	0.000861	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.67e-05	0.000854	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.66e-05	0.000852	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—systemic lupus erythematosus	4.62e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—systemic lupus erythematosus	4.62e-05	0.000846	CcSEcCtD
Acetylsalicylic acid—Rash—Dexamethasone—systemic lupus erythematosus	4.59e-05	0.000839	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—systemic lupus erythematosus	4.59e-05	0.000839	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.58e-05	0.000838	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—systemic lupus erythematosus	4.58e-05	0.000838	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—systemic lupus erythematosus	4.48e-05	0.00082	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000798	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—systemic lupus erythematosus	4.33e-05	0.000793	CcSEcCtD
Acetylsalicylic acid—Nausea—Betamethasone—systemic lupus erythematosus	4.32e-05	0.00079	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—systemic lupus erythematosus	4.32e-05	0.00079	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—systemic lupus erythematosus	4.21e-05	0.000769	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—systemic lupus erythematosus	4.19e-05	0.000766	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—systemic lupus erythematosus	4.03e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—systemic lupus erythematosus	3.99e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—systemic lupus erythematosus	3.99e-05	0.00073	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.9e-05	0.000713	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—systemic lupus erythematosus	3.76e-05	0.000688	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000685	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000663	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—systemic lupus erythematosus	3.5e-05	0.00064	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—systemic lupus erythematosus	3.37e-05	0.000616	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—systemic lupus erythematosus	3.34e-05	0.000611	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—systemic lupus erythematosus	3.33e-05	0.00061	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—systemic lupus erythematosus	3.14e-05	0.000575	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.98e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—systemic lupus erythematosus	4.94e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—systemic lupus erythematosus	4.94e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—C3—systemic lupus erythematosus	4.94e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—C3—systemic lupus erythematosus	4.94e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—systemic lupus erythematosus	4.91e-06	4.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.9e-06	4.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQA1—systemic lupus erythematosus	4.87e-06	4.65e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—F2—systemic lupus erythematosus	4.85e-06	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.81e-06	4.6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	4.8e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—F2—systemic lupus erythematosus	4.79e-06	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CDKN1A—systemic lupus erythematosus	4.76e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.76e-06	4.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CSK—systemic lupus erythematosus	4.68e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.66e-06	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CD80—systemic lupus erythematosus	4.65e-06	4.45e-05	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.65e-06	4.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TYK2—systemic lupus erythematosus	4.63e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CDKN1B—systemic lupus erythematosus	4.61e-06	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CD80—systemic lupus erythematosus	4.6e-06	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NCF2—systemic lupus erythematosus	4.59e-06	4.39e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—systemic lupus erythematosus	4.56e-06	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—LYN—systemic lupus erythematosus	4.56e-06	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—systemic lupus erythematosus	4.55e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TGFB1—systemic lupus erythematosus	4.54e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EP300—systemic lupus erythematosus	4.53e-06	4.34e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—systemic lupus erythematosus	4.52e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.5e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.48e-06	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.47e-06	4.27e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	4.44e-06	4.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.42e-06	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.4e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD247—systemic lupus erythematosus	4.4e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	4.4e-06	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	4.39e-06	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—EP300—systemic lupus erythematosus	4.38e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—F2—systemic lupus erythematosus	4.33e-06	4.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—F2—systemic lupus erythematosus	4.33e-06	4.15e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCL2—systemic lupus erythematosus	4.32e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL18—systemic lupus erythematosus	4.31e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—systemic lupus erythematosus	4.3e-06	4.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NCF2—systemic lupus erythematosus	4.28e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCL2—systemic lupus erythematosus	4.27e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CDKN1A—systemic lupus erythematosus	4.26e-06	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.26e-06	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—systemic lupus erythematosus	4.25e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—systemic lupus erythematosus	4.19e-06	4.01e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.17e-06	3.99e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CD80—systemic lupus erythematosus	4.16e-06	3.98e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CD80—systemic lupus erythematosus	4.16e-06	3.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—JAK1—systemic lupus erythematosus	4.13e-06	3.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JAK1—systemic lupus erythematosus	4.1e-06	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—systemic lupus erythematosus	4.08e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.08e-06	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EP300—systemic lupus erythematosus	4.05e-06	3.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	4.04e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—systemic lupus erythematosus	4.02e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.02e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—systemic lupus erythematosus	3.97e-06	3.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.96e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CDKN1B—systemic lupus erythematosus	3.94e-06	3.77e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TYK2—systemic lupus erythematosus	3.92e-06	3.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.88e-06	3.71e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TYK2—systemic lupus erythematosus	3.88e-06	3.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCL2—systemic lupus erythematosus	3.86e-06	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCL2—systemic lupus erythematosus	3.86e-06	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	3.86e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.86e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOS3—systemic lupus erythematosus	3.85e-06	3.68e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.85e-06	3.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2RA—systemic lupus erythematosus	3.83e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOS3—systemic lupus erythematosus	3.81e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—C3—systemic lupus erythematosus	3.8e-06	3.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	3.78e-06	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	3.73e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.73e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.67e-06	3.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.67e-06	3.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.66e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EP300—systemic lupus erythematosus	3.66e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.64e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—systemic lupus erythematosus	3.61e-06	3.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUNB—systemic lupus erythematosus	3.6e-06	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	3.58e-06	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NAT2—systemic lupus erythematosus	3.56e-06	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TYK2—systemic lupus erythematosus	3.51e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TYK2—systemic lupus erythematosus	3.51e-06	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.49e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	3.49e-06	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.47e-06	3.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR4—systemic lupus erythematosus	3.46e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.46e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—systemic lupus erythematosus	3.46e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EP300—systemic lupus erythematosus	3.46e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOS3—systemic lupus erythematosus	3.44e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.44e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	3.43e-06	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—systemic lupus erythematosus	3.42e-06	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.42e-06	3.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.37e-06	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—F2—systemic lupus erythematosus	3.36e-06	3.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JUNB—systemic lupus erythematosus	3.36e-06	3.21e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.34e-06	3.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRL—systemic lupus erythematosus	3.32e-06	3.17e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.3e-06	3.16e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—systemic lupus erythematosus	3.27e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—systemic lupus erythematosus	3.23e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD80—systemic lupus erythematosus	3.2e-06	3.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	3.19e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.18e-06	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.15e-06	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.14e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	3.12e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	3.1e-06	2.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRL—systemic lupus erythematosus	3.09e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MMP9—systemic lupus erythematosus	3.09e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.08e-06	2.95e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MMP9—systemic lupus erythematosus	3.06e-06	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.04e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.98e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.98e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—systemic lupus erythematosus	2.97e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EP300—systemic lupus erythematosus	2.93e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—systemic lupus erythematosus	2.92e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—systemic lupus erythematosus	2.92e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	2.91e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—systemic lupus erythematosus	2.9e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—systemic lupus erythematosus	2.9e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EP300—systemic lupus erythematosus	2.9e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.88e-06	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.84e-06	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.83e-06	2.7e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.78e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MMP9—systemic lupus erythematosus	2.76e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.76e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.75e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.75e-06	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.74e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TYK2—systemic lupus erythematosus	2.7e-06	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS3—systemic lupus erythematosus	2.67e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—systemic lupus erythematosus	2.65e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JAK1—systemic lupus erythematosus	2.65e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EP300—systemic lupus erythematosus	2.62e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EP300—systemic lupus erythematosus	2.62e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.56e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.55e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.54e-06	2.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—systemic lupus erythematosus	2.53e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.52e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR5—systemic lupus erythematosus	2.51e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.48e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.48e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.48e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JAK1—systemic lupus erythematosus	2.47e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	2.46e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—C3—systemic lupus erythematosus	2.46e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—systemic lupus erythematosus	2.44e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—systemic lupus erythematosus	2.4e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCR5—systemic lupus erythematosus	2.34e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.31e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1B—systemic lupus erythematosus	2.29e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.29e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.28e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.28e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.28e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—systemic lupus erythematosus	2.27e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.26e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—systemic lupus erythematosus	2.25e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.24e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.22e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—F2—systemic lupus erythematosus	2.16e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CDKN1A—systemic lupus erythematosus	2.12e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.12e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.08e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD80—systemic lupus erythematosus	2.07e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.03e-06	1.94e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—systemic lupus erythematosus	2.01e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	2e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—RXRA—systemic lupus erythematosus	1.99e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.96e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD80—systemic lupus erythematosus	1.93e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	1.92e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL2—systemic lupus erythematosus	1.92e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—systemic lupus erythematosus	1.92e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—systemic lupus erythematosus	1.9e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.86e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.85e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.82e-06	1.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	1.79e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	1.77e-06	1.69e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—systemic lupus erythematosus	1.76e-06	1.69e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.75e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TYK2—systemic lupus erythematosus	1.74e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—systemic lupus erythematosus	1.72e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—systemic lupus erythematosus	1.72e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—systemic lupus erythematosus	1.71e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	1.69e-06	1.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.66e-06	1.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.63e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.63e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.6e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.56e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.51e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.48e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—systemic lupus erythematosus	1.47e-06	1.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—systemic lupus erythematosus	1.45e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.4e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.38e-06	1.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MMP9—systemic lupus erythematosus	1.37e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.37e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.34e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—systemic lupus erythematosus	1.32e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—systemic lupus erythematosus	1.3e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.28e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.28e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	1.27e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.26e-06	1.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.23e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—systemic lupus erythematosus	1.22e-06	1.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.14e-06	1.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.13e-06	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	1.13e-06	1.08e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.1e-06	1.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.09e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.08e-06	1.04e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.06e-06	1.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.03e-06	9.85e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.02e-06	9.74e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	1.02e-06	9.72e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	9.96e-07	9.52e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—systemic lupus erythematosus	9.92e-07	9.48e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—systemic lupus erythematosus	9.9e-07	9.47e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	9.72e-07	9.3e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	9.48e-07	9.07e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	9.26e-07	8.86e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	8.89e-07	8.5e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	8.86e-07	8.48e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	8.67e-07	8.3e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—systemic lupus erythematosus	8.53e-07	8.16e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	8.28e-07	7.92e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—systemic lupus erythematosus	8.23e-07	7.88e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	8.1e-07	7.75e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—systemic lupus erythematosus	7.96e-07	7.61e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	7.39e-07	7.07e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—systemic lupus erythematosus	7.21e-07	6.9e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	6.74e-07	6.45e-06	CbGpPWpGaD
